Drug dependence as a disorder of neural plasticity: Focus on dopamine and glutamate

Reviews in the Neurosciences

Volumn 12, Issue 2, 2001, Pages 141-158

  Pulvirenti, L ^a   Diana, M ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Dopamine; Drug addiction; Drugs of abuse; Electrophysiology; Glutamate; Neural plasticity; Pharmacotherapies; Self administration

Indexed keywords

ALCOHOL; CANNABIS; DOPAMINE; GLUTAMIC ACID; NICOTINE; OPIATE; PSYCHOSTIMULANT AGENT;

AMYGDALOID NUCLEUS; BEHAVIOR DISORDER; DOPAMINERGIC ACTIVITY; DRUG DEPENDENCE; HUMAN; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REVIEW; WITHDRAWAL SYNDROME;

EID: 0035017429     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2001.12.2.141     Document Type: Review

References (168)

1. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
2. Dependence on delta 9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal
3. 10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment
4. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine
5. Transition from moderate to excessive drug intake: A change in hedonic set point
6. Demonstration and mapping out of nigro-neostriatal dopamine neurons
7. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon
8. Chronic ethanol administration alters activity in ventral tegmental area neurons after cessation of withdrawal hyperexcitability
9. The localization of monoaminergic blood-brain barrier mechanisms
10. The specific action of L-DOPA decarboxylase
11. A synaptic model of memory: Long-term potentiation in the hippocampus
12. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path
13. Increased probability of GABA release during withdrawal from morphine
14. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area
15. Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen
16. Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons
17. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity
18. Involvement of the amygdala in stimulus-reward associations: Interaction with the ventral striatum
19. Inhibition of nitric oxide formation reduces voluntary ethanol consumption in the rat
20. 2 receptor function in rats
21. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex
22. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons
23. Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex
24. Classically conditioned responses in opioid and cocaine dependence: A role in relapse?
25. Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations
26. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction
27. Nitric oxide facilitates N-methyl-D-aspartate-induced burst firing in dopamine neurons from rat midbrain slices
28. Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats
29. Localization of monoamines in the lower brain stem
30. Craving and drug reward: A comparison of methadone and clonidine in detoxifying opiate addicts
31. MK-801 reinstates drug-seeking behaviour in cocaine-trained rats
32. Reinstatement of cocaine-reinforced responding in the rat
33. Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system
34. Rewarding and aversive effects of ethanol: Interplay of GABA, glutamate and dopamine
35. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: Electrophysiological and biochemical evidence
36. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats
37. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system
38. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: Evidence of protracted abstinence
39. Dopaminergic neurotransmission and drug withdrawal
40. Drugs of abuse and dopamine cell activity
41. Mesolimbic dopaminergic decline after cannabinoid withdrawal
42. Increase in mesoprefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
43. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
44. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
45. Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: Possible dependence on dopaminergic mechanisms
46. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum
47. Conditioned response to cocaine related stimuli in cocaine abuse patients
48. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Studies in the ventral tegmental area
49. Interactions between the amygdala and ventral striatum in stimulus-reward associations: Studies using a second-order schedule of sexual reinforcement
50. Fluorescence of catechol amines and related compounds condensed with formaldehyde
51. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
52. Delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
53. Effects of nicotine on dopaminergic nigrostriatal axons requires stimulation of presynaptic glutamatergic receptors
54. Marijuana's interaction with brain reward systems: Update
55. Glutamate, nitric oxide and cell-cell signalling in the nervous system
56. Drug-induced reinstatement of extinguished self-administration behavior in monkey
57. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems
58. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area
59. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
60. Marihuana
61. Self-inhibition by dopaminergic neurons
62. Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra
63. Morphine-induced activation of A10 dopamine neurons in the rat
64. Effects of nitric oxide synthase inhibitors on cocaine sensitization
65. 2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
66. 1 dopamine receptor sensitivity within the rat nucleus accumbens
67. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
68. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal
69. Alcohol self-administration: Further examination of the role of dopamine receptors in the nucleus accumbens
70. Ethanol and the NMDA receptor
71. Ethanol, sedative hypnotics and glutamate receptor function in brain and cultured cells
72. Partial agonists, full agonists, antagonists: Dilemma of definition
73. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo
74. Synaptic plasticity: A role for nitric oxide in LTP
75. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats
76. Dopamine release in the nucleus caudatus and nucleus accumbens is under glutamatergic control through non-NMDA receptors: A study in freely-moving rats
77. The neuronal nitric oxide synthase inihibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo
78. Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase
79. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons
80. Opioids excite dopamine neurons by hyperpolarization of local interneurons
81. Amphetamine blocks long term synaptic depression in the ventral tegmantal area
82. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
83. DNQX blockade of amphetamine behavioral sensitization
84. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde and retrograde horseradish peroxidase study
85. The amygdalostriatal projection in the rat: An anatomical study by anterograde and retrograde tracing methods
86. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens
87. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: Ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice
88. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor
89. 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance
90. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens
91. Neuroscience of addiction
92. Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence
93. Drug abuse: Hedonic homeostatic dysregulation
94. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
95. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization
96. Ethanol inhibition of neuronal glutamate receptor function
97. Alcohol craving
98. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat
99. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal
100. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine
101. Pharmacological characterization of the discriminative-stimulus effects of GBR12909
102. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures
103. Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats
104. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine
105. Low doses of ethanol inhibit the firing of neurons in the substantia nigra, pars reticulata: A GABAergic effect?
106. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata
107. From motivation to action: Functional interface between the limbic system and the motor system
108. Influence of dopamine on limbic inputs to the nucleus accumbens
109. Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain
110. Drug addiction: A model for the molecular basis of neural plasticity
111. Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms
112. Persistent increase in dopamine release following activation of metabotropic glutamate receptors in rat nucleus accumbens
113. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome
114. Synaptic plasticity in an in vitro slice preparation of the rat nucleus accumbens
115. Contribution of NMDA receptors to postsynaptic potentials and paired-pulse facilitation in identified neurons of the rat nucleus accumbens in vivo
116. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats
117. Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size
118. The NMDA antagonist dizocilpine enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission
119. Nicotine activates and desensitizes midbrain dopamine neurons
120. 3 agonist
121. 1 agonists
122. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine
123. NMDA receptors in the nucleus accumbens modulate intravenous cocaine, but not heroin self-administration, in the rat
124. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat
125. Dopamine receptor agonists, partial agonists and psychostimulant addiction
126. Inhibition of nitric oxide synthesis reduces cocaine self-administration in the rat
127. Enhanced synaptic efficacy in the nucleus accumbens during the acquisition of cocaine self-administration
128. Systemic pretreatment with MK-801 (dizocilpine) increases breaking point for self-administration of cocaine on a progressive ratio schedule in rats
129. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens
130. Functions of dopamine in the dorsal and ventral striatum
131. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
132. The neural basis of drug craving: An incentive-sensitization theory of addiction
133. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum
134. Glutamate-induced increase of extracellular glutamate through N-methyl-D-aspartate receptors in ethanol withdrawal
135. Sensitization and tolerance in psychostimulant self-administration
136. In the rat medial nucleus accumbens hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other
137. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamne terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area
138. Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area
139. Topographic organization of collateral projections from the basolateral amygdaloid nucleus to both the prefrontal cortex and nucleus accumbens in the rat
140. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons
141. 2 partial agonists terguride, SDZ 208-911, and SDZ 208-912
142. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs
143. Drugs of abuse: Behavioural principles, methods and terms
144. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
145. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs
146. Enhanced behavioral control by conditioned reinforcers following microinjection of d-amphetamine into the nucleus accumbens
147. A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons
148. Modulation of long-term depression by dopamine in the mesolimbic system
149. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
150. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists
151. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal
152. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
153. Stereotaxic mapping of the monoamine pathways in the rat brain
154. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat
155. Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrelly and peripherally mediated effects
156. 1 receptor agonists in rhesus monkeys
157. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats
158. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: Role of ionotropic glutamate receptor-dependent mechanisms
159. Inhibition of glutamate re-uptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: An in vivo microdialysis study
160. Synaptic regulation of mesocorticolimbic dopamine neurons
161. Cocaine abuse and dependence
162. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections
163. The neurobiology of craving: Implications for the understanding and treatment of addiction
164. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine
165. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine
166. Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine
167. Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens